RGEN

#1098
Repligen Corporation - Common Stock
124.9 1 USD
+1.78%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
1.24
125.20
Yıllık Aralık
1.12
175.57
Günlük Değişim
+1.78%
Aylık Değişim
+9.49%
6 Aylık Değişim
-25.90%
Yıllık Değişim
-24.61%
Önceki Kapanış
122.7 3
Open
1.2 5
Düşük
1.2 4
High
125.2 0
Hacim
122
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
  • Market Capitalization 7.05 B
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Tıbbi Aletler ve Malzemeler
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
190.53
Fiyat/satışlar oranı
0.01

Repligen Corporation - Common Stock

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Haberler